Business Information
The group’s principal activities include researching, developing, manufacturing, and marketing integrative medical devices in the healthcare industry. Products of the group include Meridian-II, ABR-2000, Lapex–2000, Digital Pulse Analyzer and Venus 21C. In September 2005, the group acquired Rapha & Health Co., Ltd. The group operates from the United States, South Asia and China. The revenue of the group in the year 2005, were $1,434,519,243.
|
|
Name |
Title
|
Email
|
| Hyeon-Seong Myeong | Dir., CEO, Pres. | N/A | | In Park | Dir., Sec. | N/A | | Soon Jang | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2005 | 1,420 | (3,316) | | 2004 | 2,129 | (1,986) | | 2003 | 2,895 | (2,244)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
